ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,08165
0,00%
Bitcoin
69.408,17
0,11%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Australien
  5. ASX
  6. Brumby Res Fpo (BMY)

  7. Brumby Res Fpo (BMY) News

BMY

Brumby Resources (BMY)

Brumby Res Fpo
Von:
Sortieren nach:
 Showing the most relevant articles for your search:ASX:BMY
DatumZeitQuelleÜberschriftSymbolFirma
16/10/200922h56Dow Jones NewsUPDATE: Bristol-Myers Cuts Abilify Sales Force By About 25%NYSE:BMYBristol-Myers Squibb Co.
16/10/200915h29Dow Jones NewsBristol-Myers Reduces Abilify Sales Force By About 25%NYSE:BMYBristol-Myers Squibb Co.
05/10/200917h04Dow Jones NewsEU OKs AstraZeneca, Bristol Diabetes Drug For MarketingNYSE:BMYBristol-Myers Squibb Co.
05/10/200916h23Dow Jones NewsAstraZeneca: Onglyza EU Marketing AuthorisationNYSE:BMYBristol-Myers Squibb Co.
02/10/200911h45Dow Jones NewsAstraZeneca Reports Phase III Success For DapagliflozinNYSE:BMYBristol-Myers Squibb Co.
01/10/200922h48Dow Jones NewsDiabetes Drug From Astra, Bristol Shows Benefit In StudyNYSE:BMYBristol-Myers Squibb Co.
29/09/200922h14Dow Jones NewsUPDATE: Danone Denies Speculation Regarding Mead JohnsonNYSE:BMYBristol-Myers Squibb Co.
23/09/200916h22Dow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesNYSE:BMYBristol-Myers Squibb Co.
23/09/200915h22Dow Jones NewsErbitux Succeeds In One Trial, Disappoints In AnotherNYSE:BMYBristol-Myers Squibb Co.
23/09/200911h59Dow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerNYSE:BMYBristol-Myers Squibb Co.
21/09/200920h52Dow Jones NewsUPDATE:Lilly Drug Launch Seen Sluggish But CFO Sees ProgressNYSE:BMYBristol-Myers Squibb Co.
21/09/200920h28Dow Jones NewsLilly Drug Launch Seen Sluggish But CFO Says Progress MadeNYSE:BMYBristol-Myers Squibb Co.
17/09/200915h31Dow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixNYSE:BMYBristol-Myers Squibb Co.
16/09/200906h29Dow Jones NewsUPDATE:Taisho To Buy Bristol-Myers Asian OTC Assets For $310 MillionNYSE:BMYBristol-Myers Squibb Co.
16/09/200905h00Dow Jones NewsTaisho Pharma: To Acquire Bristol-Myers OTC Rights In AsiaNYSE:BMYBristol-Myers Squibb Co.
08/09/200923h11Dow Jones News3rd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
08/09/200919h08Dow Jones News2nd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
08/09/200917h40Dow Jones NewsUPDATE: Facet Again Shuns Biogen Offer, Adopts Poison PillNYSE:BMYBristol-Myers Squibb Co.
31/08/200912h30Dow Jones NewsStudy: Popular Heartburn Drugs Don't Interfere With PlavixNYSE:BMYBristol-Myers Squibb Co.
30/08/200908h30Dow Jones NewsHigh-Dose Plavix Misses Goal But Helps Some In StudyNYSE:BMYBristol-Myers Squibb Co.
28/08/200920h59Dow Jones NewsUS EQUITIES WEEK AHEAD: Aug Jobs Data, Auto, Retail Sales DueNYSE:BMYBristol-Myers Squibb Co.
28/08/200917h46Dow Jones NewsUPDATE: Boehringer's Blood-Thinner May Edge Out Bayer'sNYSE:BMYBristol-Myers Squibb Co.
28/08/200912h57Dow Jones NewsBoehringer Ingelheim's Blood-Thinner May Edge Out Bayer'sNYSE:BMYBristol-Myers Squibb Co.
25/08/200923h12Dow Jones NewsUPDATE: Study: Plavix Less Effective In Certain PatientsNYSE:BMYBristol-Myers Squibb Co.
25/08/200922h30Dow Jones NewsJAMA Study Shows Plavix Ineffective In Certain PatientsNYSE:BMYBristol-Myers Squibb Co.
20/08/200923h42Dow Jones NewsBristol-Myers Squibb Extends Medarex Tender Offer DeadlineNYSE:BMYBristol-Myers Squibb Co.
19/08/200901h53Dow Jones NewsPreliminary Approval Given To Bristol-Myers Holder PactsNYSE:BMYBristol-Myers Squibb Co.
18/08/200922h51Dow Jones News2nd UPDATE: US Patent Office Orders Re-Exam Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
18/08/200919h06Dow Jones NewsUPDATE: US Patent Office Orders Re-Exam Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
18/08/200917h41Dow Jones NewsUS Patent Office Orders Re-Examination Of Plavix PatentNYSE:BMYBristol-Myers Squibb Co.
 Showing the most relevant articles for your search:ASX:BMY

Kürzlich von Ihnen besucht

PM
XAUUSD
Gold vs US Dollar
TG
BAYN
Bayer
DBI
TDXP
Tec DAX
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
DBI
MDAX
MDAX
CCOM
US500
US 500
NASDAQ
AAPL
Apple
TG
DBK
Deutsche Bank
CCOM
US100
US Tech 100
COIN
ETHUSD
Ethereum
USOTC
RHHBY
Roche (QX)
DBI
SDXP
SDAX
TG
LHA
Deutsche Lufthansa
TG
RHM
Rheinmetall
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten